- Clear All
- Remove thePolicyfilter Policy
- Remove thePreventive medicinefilter Preventive medicine
- Remove theToxicologyfilter Toxicology
- Remove theBiosecurityfilter Biosecurity
- Remove theNational legislation & regulationfilter National legislation & regulation
- Remove theProduction medicinefilter Production medicine
Your search for 'Production medicine' has returned 3 results
policy
Guidelines for use of exempt biologics
State-licensed veterinarians may consider preparing biologics in their practice facility under a VCPR in unique disease situations not adequately…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.